Aralez Pharmaceuticals released their financial results for the first quarter of 2017.
Aralez Pharmaceuticals (NASDAQ:ARLZ, TSX:ARZ) released their financial results for the first quarter of 2017.
As quoted in the press release:
- First Quarter Financial Results
- Revenues of $2.109 Billion
- GAAP Net Income of $628 Million
- GAAP Cash Flow from Operations of $954 Million
- Adjusted EBITDA (non-GAAP) of $861 Million
- Adjusted Net Income (non-GAAP) of $273 Million
- Reduced Debt by $1.3 Billion in the quarter
- Raising 2017 Full Year Adjusted EBITDA Guidance Range
The Company also highlighted certain recent corporate and commercial achievements. All figures are in U.S. dollars.
“We are pleased to report a solid first quarter of 2017, together with important updates to our business addressing a number of the challenges we face,” said Adrian Adams, Chief Executive Officer of Aralez. “We are making a bold and significant change to our pricing strategy for Yosprala® aimed at allowing all patients to access the product for only $10.00 per month. In addition, we continue to implement our cost savings plan to further improve our cost structure and balance sheet to maximize and preserve our financial flexibility. Our updated financial guidance for 2017 reflects our commitment to reaching break-even on an Adjusted EBITDA basis this year. We also continue to opportunistically look at business development opportunities with a strong focus on value creating and transformative M&A with the goal of enhancing shareholder value.”
Click here to read the full press release.
Source: www.newswire.ca
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1923.00 | +0.91 | |
Silver | 23.60 | +0.02 | |
Copper | 4.19 | -0.01 | |
Palladium | 1713.17 | 0.00 | |
Platinum | 1087.26 | 0.00 | |
Oil | 78.74 | +0.84 | |
Heating Oil | 3.14 | +0.08 | |
Natural Gas | 2.70 | +0.02 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Featured Pharmaceutical Investing Stocks
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.